Sartorius Stedim Biotech S.A. SDMHF
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | 39.13% | 13.28% | 50.79% | 47.13% | |
| Total Depreciation and Amortization | 4.45% | -10.13% | 10.26% | 7.19% | |
| Total Amortization of Deferred Charges | -- | 35.34% | -- | -- | |
| Total Other Non-Cash Items | -49.63% | 202.21% | -31.76% | 84.66% | |
| Change in Net Operating Assets | 24.54% | -53.16% | -253.05% | -94.44% | |
| Cash from Operations | 21.35% | -5.51% | -39.11% | 109.62% | |
| Capital Expenditure | 1.71% | -59.85% | 0.21% | 42.03% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -828.24% | -- | -- | |
| Cash from Investing | 2.98% | -61.77% | -1.11% | 42.03% | |
| Total Debt Issued | 2,185.27% | -89.19% | -5.15% | -- | |
| Total Debt Repaid | -- | 100.00% | 100.00% | 97.51% | |
| Issuance of Common Stock | 118.18% | 50.00% | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -2.48% | -- | -5.44% | -- | |
| Other Financing Activities | -44,450.00% | 57.95% | 99.27% | -17.86% | |
| Cash from Financing | -658.70% | 108.62% | 85.06% | -103.92% | |
| Foreign Exchange rate Adjustments | 175.15% | -142.27% | -251.48% | -190.70% | |
| Miscellaneous Cash Flow Adjustments | -2.47% | -- | -- | -3.13% | |
| Net Change in Cash | -3,772.29% | -29.16% | 96.32% | -95.19% | |